FMC & Corteva Unite: A New Front in the War on Herbicide-Resistant Weeds

PHILADELPHIA and INDIANAPOLIS, June 16, 2026 – In a significant consolidation of power within the global agriscience sector, FMC Corporation and Corteva, Inc. today announced a decade-long strategic alliance to deploy a groundbreaking new herbicide technology. The co-exclusive deal centers on FMC’s rimisoxafen, a molecule designed to combat the growing scourge of herbicide-resistant weeds that threatens crop yields and farm profitability across the Americas.

The agreement sees Corteva making a $200 million prepurchase payment to FMC for the novel active ingredient. Both agricultural titans will then independently develop and market their own proprietary herbicide blends based on rimisoxafen for the lucrative North and South American corn and soybean markets. For farmers locked in a seemingly losing battle with "superweeds," this collaboration could represent a desperately needed technological breakthrough. For the companies, it's a calculated move to secure market dominance in a sector defined by relentless innovation and high stakes.

The Science of a Superweed Slayer

At the heart of this billion-dollar handshake is the unique chemistry of rimisoxafen. The Herbicide Resistance Action Committee (HRAC), the global body that classifies crop protection products, has designated it as the industry's first-ever dual mode of action herbicide. This is not just a marketing label; it represents a fundamental shift in the chemical war against weeds.

For decades, farmers have relied on single mode of action herbicides, which attack a single specific biological process within a weed. Over time, through natural selection, weeds can develop genetic mutations that render that single point of attack useless, leading to widespread resistance. This evolutionary arms race has left many common herbicides ineffective against resilient invaders like Palmer amaranth and waterhemp, which can devastate crop yields. Palmer amaranth alone has developed resistance to chemicals spanning eight different modes of action.

Rimisoxafen, a pyrimidinyloxy benzene herbicide discovered by FMC scientists, attacks weeds on two fronts simultaneously. It inhibits two separate and essential plant enzymes: phytoene desaturase (PDS) and solanesyl diphosphate synthase (SDPS). These enzymes are critical for photosynthesis and other vital functions. By knocking out both pathways at once, the herbicide creates a significantly higher barrier to resistance. For a weed to survive, it would need to develop two distinct and complex mutations concurrently—a statistical improbability.

"This agreement ensures that more growers across the Americas will have access to rimisoxafen, one of the most innovative herbicide technologies developed in decades," said Leonardo Bastos, FMC vice president and chief marketing officer, in the official announcement. This dual-action approach provides a much-needed tool for durable weed management, promising to extend the effective life of chemical solutions.

A Strategic Alliance in a High-Stakes Market

The deal's structure reveals as much about market strategy as it does about agricultural science. FMC, which retains full ownership of the rimisoxafen intellectual property, gets a significant cash infusion and a powerful partner to accelerate market penetration. The $200 million prepurchase from Corteva provides immediate capital for a company that has faced recent financial headwinds, including declining revenues. For the Philadelphia-based FMC, this partnership validates its innovation pipeline and leverages its core strength in R&D to generate revenue without bearing the full cost of commercialization alone.

For Corteva, the agreement is a shrewd strategic move to bolster its already formidable portfolio. The Indianapolis-based firm, which has enjoyed strong financial performance and rising dividends, gains access to a next-generation technology that complements its existing products. "This agreement supports our long-term strategy of forging new collaborations that drive value for farmers, as well as a unique growth opportunity with attractive economics," stated Cynthia Ericson, Corteva's vice president for the weed control segment.

By forming a co-exclusive partnership rather than a full acquisition or a standard licensing deal, the two giants can dominate the market while still competing. Both will sell their own rimisoxafen-based formulations, creating a market duopoly for this specific technology in the Americas' corn and soy sectors. This approach effectively blocks other major competitors like Bayer or Syngenta from accessing the novel molecule for these key crops, while allowing FMC to pursue opportunities in other crops and geographies globally. It’s a classic case of coopetition, where rivals collaborate to grow the pie and then compete for the biggest slice.

The View from the Field

Beyond the corporate boardrooms, the impact of this deal will be most profoundly felt in the fields of North and South America. Farmers are currently facing a crisis of efficacy. The tools they have relied on for decades are failing, and the economic consequences are dire, with resistant weeds costing the industry billions of dollars annually in lost yields and increased control costs.

"We're running out of options," one agricultural consultant noted. "Growers are having to layer multiple pre- and post-emergent herbicides, increase tillage which can harm soil health, and even resort to manual weeding on a scale not seen in generations. It's unsustainable."

While futuristic, non-chemical solutions like electric weed "zappers" and AI-powered spot-spraying drones are emerging, their cost, speed, and scalability remain significant hurdles for the vast acreages of commodity crops like corn and soybeans. The reality for most growers is that effective, reliable chemical herbicides remain the cornerstone of their weed management programs.

The introduction of a new dual mode of action chemistry is therefore a landmark event. It offers a chance to reset the clock on resistance for some of the most troublesome weeds. By integrating rimisoxafen into their rotation, farmers can attack resistant weed populations with a mechanism they haven't encountered before, helping to preserve the effectiveness of older chemistries as well. The success of this new technology will hinge on its performance, price, and how effectively it is integrated into comprehensive weed management plans that prioritize long-term sustainability over short-term fixes.

The Path to Market and a Sustainable Future

Despite the excitement, growers will have to wait. The first commercial sales of rimisoxafen-based products are not expected until the end of the decade. FMC plans to begin submitting the extensive regulatory dossiers to agencies like the U.S. Environmental Protection Agency (EPA) and its counterparts in Canada and Brazil starting in 2026. This multi-year process involves rigorous evaluation of the herbicide's efficacy, toxicology, and environmental impact.

The promise of this new technology extends beyond just killing weeds more effectively. By providing a more robust and durable solution, a dual-action herbicide could potentially lead to a reduction in the total volume of chemicals applied to fields over the long term. If one application of a smarter herbicide can replace multiple applications of older, less effective ones, the environmental load could be lessened. This aligns with the industry's broader push toward solutions that are, as FMC's mission states, "consistently better for the planet."

The FMC-Corteva alliance is a clear signal that even as the agricultural industry explores digital and biological frontiers, innovation in core crop protection chemistry remains a critical driver of progress. This collaboration pools the R&D prowess of one company with the market-facing power of another, creating a formidable force aimed at solving one of agriculture's most persistent and costly challenges.